ZURA Stock Analysis: Buy, Sell, or Hold?
ZURA - Zura Bio Limited Class A Ordinary Shares
$5.57
-0.06 (-1.07%)
âŧ
5d:
-6.62%
30d:
+6.1%
90d:
+15.32%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ZURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ZURA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ZURA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ZURA is currently trading at $5.57, which is considered slightly high relative to its 30-day fair value range of $5.24 to $5.67.
Technical Outlook: Technically, ZURA is showing sideways momentum. Immediate support is located at $5.26, while resistance sits at $6.01.
Market Sentiment: ZURA scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.00 (+237.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZURA is showing sideways momentum. Immediate support is located at $5.26, while resistance sits at $6.01.
Market Sentiment: ZURA scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.00 (+237.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$5.24 -
$5.67
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 237.5% below Wall St target ($19.00)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.24 -
$5.67
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$5.26
Resistance Level
$6.01
Current Trend
Sideways
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.82
Wall Street Target
$19.00
(+237.5%)
Share & Embed Analysis
Last updated: August 16, 2026 2:50 AM ET
Data refreshes hourly during market hours. Next update: 3:50 AM
Data refreshes hourly during market hours. Next update: 3:50 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZURA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ai Biotechnology Llc
BUY
2000000 shares
2026-02-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 60 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 55 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 46 HOLD |
